FILE:BSX/BSX-8K-20110110092025.txt.gz
EVENTS:	Results of Operations and Financial Condition	Other Events
TEXT:
ITEM: Results of Operations and Financial Condition
ITEM: Other Events
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, DC 20549
_____________________________________________________________________
 
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
______________________________________________________________________
 
Date of Report (Date of earliest event reported): January 10, 2011
 
BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in charter)
 
 
 
Registrant's telephone number, including area code:   
(508) 650-8000
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
 
Boston Scientific Corporation expects to record a pre-tax gain, not included in previous guidance, of approximately $104 million ($77 million after-tax, or $0.05 per share) during the fourth quarter of 2010 associated with a settlement agreement entered into with Medinol Ltd. on December 27, 2010.
 
ITEM 8.01. OTHER EVEN TS.
 
On December 27, 2010, Boston Scientific Corporation reached a settlement with Medinol Ltd. resolving the dispute between the two companies that has been the subject of an arbitration before the American Arbitration Association in New York City. Under the terms of the settlement, Medinol paid Boston Scientific approximately $104 million on December 30, 2010, and the parties have canceled and terminated certain provisions of their September 21, 2005 Settlement Agreement and mutually released each other of all claims in the arbitration.
 
 
 
 
SIGNATURE
 
 
Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf b y the undersigned hereunto duly authorized.
 
                        
                            
    
&n bsp;
 
 


